Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
Stopped Low Accrual
Conditions
- Cutaneous T-cell Lymphoma
Interventions
- DRUG: Romidepsin
- DRUG: Poly ICLC
- RADIATION: Focal lesional radiation
Sponsor
NYU Langone Health
Collaborators